Correlation Between Virpax Pharmaceuticals and Immunocore Holdings
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Immunocore Holdings, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Immunocore Holdings.
Diversification Opportunities for Virpax Pharmaceuticals and Immunocore Holdings
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Virpax and Immunocore is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Immunocore Holdings go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Immunocore Holdings
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to generate 4.63 times more return on investment than Immunocore Holdings. However, Virpax Pharmaceuticals is 4.63 times more volatile than Immunocore Holdings. It trades about 0.0 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.06 per unit of risk. If you would invest 395.00 in Virpax Pharmaceuticals on August 27, 2024 and sell it today you would lose (338.00) from holding Virpax Pharmaceuticals or give up 85.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Immunocore Holdings
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Immunocore Holdings |
Virpax Pharmaceuticals and Immunocore Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Immunocore Holdings
The main advantage of trading using opposite Virpax Pharmaceuticals and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Immunocore Holdings vs. Arcellx | Immunocore Holdings vs. Ventyx Biosciences | Immunocore Holdings vs. Vaxcyte | Immunocore Holdings vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |